M. Schuetz, “Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer”, AO, vol. 49, no. 7, pp. 941–947, Oct. 2010.